Company: OCEA
Filing Date: 2025-03-26
Form Type: 8-K
Source: 0001641172-25-000747
Chunk: 0

Company: Ocean Biomedical, Inc.
Filing Date: 2025-03-26
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item
8.01 Other Information

On
March 26, 2025, in accordance with Section 7(g) of the Company’s promissory note to an institutional investor issued pursuant to
the financing transaction executed on May 15, 2023, the Company has irrevocably and permanently lowered the Conversion Price (as defined
in such note) from $1.50 to $0.01 per Share with respect to an aggregate Conversion Amount of $400,000 (the “ Reduced Conversion
Amount”). The Company may not redeem or prepay such Reduced Conversion Amount. Capitalized terms not otherwise defined herein,
shall have the meaning ascribed thereto in such note.

SIGNATURE

Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.

Date:
March 26, 2025

  OCEAN                                    
  By:                   /s/                
                        Jolie              
                        Chief